We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+10.74%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$20.8B
AUM Growth
+$3.81B
Cap. Flow
+$2.41B
Cap. Flow %
11.56%
Top 10 Hldgs %
30.36%
Holding
2,920
New
199
Increased
391
Reduced
1,521
Closed
76

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$974M
2
AMZN icon
Amazon
AMZN
+$604M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$220M
4
BAC icon
Bank of America
BAC
+$83.7M
5
AMD icon
Advanced Micro Devices
AMD
+$72.1M

Top Sells

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$49.7M
2
NVDA icon
NVIDIA
NVDA
+$37.1M
3
MSFT icon
Microsoft
MSFT
+$33.4M
4
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$28.9M
5
IWM icon
iShares Russell 2000 ETF
IWM
+$28.8M

Sector Composition

Rank Sector Weight
1 Technology 30.99%
2 Financials 13.3%
3 Consumer Discretionary 10.8%
4 Healthcare 9.36%
5 Industrials 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANNX icon
2501
Annexon
ANNX
$857M
$136K ﹤0.01%
44,632
-14,390
-24% -$35.7K
LPRO
2502
DELISTED
Open Lending Corp
LPRO
$136K ﹤0.01%
64,442
-3,037
-5% -$6.87K
INSP icon
2503
Inspire Medical Systems
INSP
$1.68B
$136K ﹤0.01%
1,831
+53
+3% +$5.37K
SKYH icon
2504
Sky Harbour Group
SKYH
$381M
$136K ﹤0.01%
13,741
– –
OSUR icon
2505
OraSure Technologies
OSUR
$276M
$135K ﹤0.01%
42,110
-4,914
-10% -$15.4K
RVMD icon
2506
Revolution Medicines
RVMD
$43.3B
$135K ﹤0.01%
2,890
+3
+0.1% +$117
RMNI icon
2507
Rimini Street
RMNI
$468M
$134K ﹤0.01%
28,628
-2,705
-9% -$12K
ATXS
2508
DELISTED
Astria Therapeutics
ATXS
$134K ﹤0.01%
18,366
-6,587
-26% -$44.6K
EDIT icon
2509
Editas Medicine
EDIT
$438M
$134K ﹤0.01%
38,517
-13,438
-26% -$37.5K
AVIR icon
2510
Atea Pharmaceuticals
AVIR
$404M
$133K ﹤0.01%
45,945
+420
+0.9% +$1.43K
JOUT icon
2511
Johnson Outdoors
JOUT
$510M
$133K ﹤0.01%
3,285
– –
CERS icon
2512
Cerus
CERS
$578M
$132K ﹤0.01%
83,180
-27,585
-25% -$37.3K
BNTC icon
2513
Benitec Biopharma
BNTC
$433M
$132K ﹤0.01%
9,397
– –
JHX icon
2514
James Hardie Industries
JHX
$18B
$132K ﹤0.01%
+6,850
New +$164K
PLTK icon
2515
Playtika
PLTK
$957M
$131K ﹤0.01%
33,771
-1,853
-5% -$7.56K
RMR icon
2516
The RMR Group
RMR
$343M
$130K ﹤0.01%
8,290
– –
ALMS
2517
Alumis Inc
ALMS
$3.1B
$130K ﹤0.01%
+32,589
New +$134K
SMC
2518
Summit Midstream
SMC
$477M
$130K ﹤0.01%
6,308
– –
FCCO icon
2519
First Community Corp
FCCO
$324M
$129K ﹤0.01%
4,587
– –
ARQ icon
2520
Arq
ARQ
$100M
$129K ﹤0.01%
18,034
-1,304
-7% -$8.61K
SLQT icon
2521
SelectQuote
SLQT
$129M
$129K ﹤0.01%
65,829
-16,787
-20% -$35.5K
SRTA
2522
Strata Critical Medical Inc
SRTA
$531M
$129K ﹤0.01%
+25,472
New +$113K
QRVO icon
2523
Qorvo
QRVO
$8.68B
$129K ﹤0.01%
1,414
-137
-9% -$12.2K
OMDA
2524
Omada Health Inc
OMDA
$1.48B
$129K ﹤0.01%
+5,822
New +$119K
MPAA icon
2525
Motorcar Parts of America
MPAA
$234M
$129K ﹤0.01%
7,772
-3,421
-31% -$46.5K
99 100
101
102 103

Similar funds

Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
NAM
Nissay Asset Management Tokyo, Japan $18.9B AUM 27.21% 1-Year Est. Return

MetLife Investment Management's Q3 2025 Portfolio in Review

As of Q3 2025, MetLife Investment Management held 2,920 positions worth $20.8B, up 22% from $17B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

MetLife Investment Management deployed $2.41B of net new capital in Q3 2025, opening 199 new positions and adding to 391 existing holdings. Its largest new stake was Apple: 4,311,733 shares worth $1.1B.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 27% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was NVIDIA, an estimated $37.1M trimmed.

  • MetLife Investment Management's largest Q3 2025 buy was Apple: 4,311,733 shares worth $1.1B.
  • MetLife Investment Management added most to Applovin in Q3 2025, an estimated $29.1M increase.
  • MetLife Investment Management's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $37.1M.
  • MetLife Investment Management fully exited RTX Corp in Q3 2025, selling an estimated $49.7M.
  • MetLife Investment Management's ten largest holdings make up 30% of its $20.8B portfolio in Q3 2025.
  • MetLife Investment Management opened 199 new positions and closed 76 in Q3 2025.
  • MetLife Investment Management's portfolio value rose 22% quarter-over-quarter to $20.8B.

Based on MetLife Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.